Direxion Daily Pharmaceutical & Medical Bull 3X Shares Rating $6.00 +0.20 (+3.36%) As of 01:35 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock Direxion Daily Pharmaceutical & Medical Bull 3X Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PILL Aggregate RatingModerate Buy 2.69Holdings in PILL have an aggregate rating of Moderate Buy based on 224 analyst ratings issued in the past year covering 21 companies (50.0% of the portfolio).PILL Aggregate Price Target$5.99-0.33% DownsideHigh Prediction$5.99Average Prediction$5.99Low Prediction$5.99Holdings in PILL have an aggregate price target of $5.99 and a range of $5.99 to $5.99 covering 21 companies (50.0% of the portfolio).PILL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy7 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily Pharmaceutical & Medical Bull 3X Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 PILL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.75%PFEPfizer$24.48+1.0%4.9867 of 5 stars2.39$28.12 14.9%18Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision2.74%RPRXRoyalty Pharma$37.74+2.0%4.9283 of 5 stars3.25$49.00 29.9%4Earnings Report2.72%ELANElanco Animal Health$16.49+0.0%3.3476 of 5 stars2.88$16.17 -1.9%8Trending NewsEarnings Report2.71%VTRSViatris$9.60+2.2%1.811 of 5 stars1.80$10.40 8.4%5News CoverageEarnings ReportDividend AnnouncementShort Interest ↑2.66%MRKMerck & Co., Inc.$80.81+0.5%4.9978 of 5 stars2.35$107.44 33.0%20Positive News2.64%JNJJohnson & Johnson$173.49+1.1%4.6842 of 5 stars2.65$174.50 0.6%20Positive News2.64%AXSMAxsome Therapeutics$103.60-0.7%4.8432 of 5 stars3.07$178.00 71.8%15Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision2.61%PRGOPerrigo$22.86+0.1%4.693 of 5 stars2.40$33.00 44.4%5News CoverageEarnings ReportAnalyst Forecast2.60%OGNOrganon & Co.$9.17+0.6%4.8395 of 5 stars2.50$18.00 96.4%6Earnings ReportDividend Announcement2.60%JAZZJazz Pharmaceuticals$111.47-0.5%4.3003 of 5 stars2.93$181.43 62.8%14Trending NewsEarnings ReportAnalyst Forecast2.53%TARSTarsus Pharmaceuticals$47.84-0.2%2.5258 of 5 stars3.00$66.67 39.3%7News CoveragePositive NewsEarnings ReportAnalyst Revision2.53%LLYEli Lilly and Company$634.11-1.1%4.9741 of 5 stars2.68$999.50 57.6%22Trending NewsEarnings ReportAnalyst DowngradeGap UpHigh Trading Volume2.52%CORTCorcept Therapeutics$72.71+1.7%4.6546 of 5 stars3.00$134.50 85.0%5Insider Trade2.50%ZTSZoetis$147.80-0.3%4.807 of 5 stars2.70$204.63 38.4%10Positive NewsEarnings ReportAnalyst Revision2.47%BMYBristol Myers Squibb$45.86+1.1%4.6283 of 5 stars2.24$56.38 22.9%21Positive NewsAnalyst Downgrade2.43%PBHPrestige Consumer Healthcare$64.81-4.1%4.5531 of 5 stars2.50$93.33 44.0%6Trending NewsEarnings Report1.97%HRMYHarmony Biosciences$34.25+0.2%4.7056 of 5 stars3.00$51.00 48.9%10Earnings ReportAnalyst Revision1.73%PCRXPacira BioSciences$24.63+3.6%3.0676 of 5 stars2.44$25.75 4.6%9Earnings Report1.65%ANIPANI Pharmaceuticals$80.79+17.1%3.2407 of 5 stars3.00$78.88 -2.4%9News CoverageEarnings ReportAnalyst ForecastGap UpHigh Trading Volume1.55%AMRXAmneal Pharmaceuticals$8.51+3.6%3.6321 of 5 stars3.00$11.60 36.4%5Earnings Report1.47%OCULOcular Therapeutix$12.22-0.7%3.7962 of 5 stars3.00$17.20 40.8%5News CoverageEarnings ReportAnalyst ForecastAnalyst Revision This page (NYSEARCA:PILL) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredGold Hit $3,500. Here’s What’s Next…Gold just smashed through $3,500—and some experts believe that’s only the beginning. With big banks like Goldm...Reagan Gold Group | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily Pharmaceutical & Medical Bull 3X Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily Pharmaceutical & Medical Bull 3X Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
